跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
immune killer cells
首页
药物
immune killer cells
immune killer cells
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CD19-DIRECTED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF IN IMMUNOTHERAPY
EP 3773918 A1
申请人: NKARTA INC
优先权: 2019
CN
EP
US
WO
14 件公开
COMBINATION THERAPY OF ARMS AND NATURAL KILLER CELLS
EP 3898701 A4
申请人: KLEO PHARMACEUTICALS INC
优先权: 2018
CN
EP
US
WO
7 件公开
CONSTITUTIVE EXPRESSION OF COSTIMULATORY LIGANDS ON ADOPTIVELY TRANSFERRED T LYMPHOCYTES
EP 3357338 A1
申请人: MEMORIAL SLOAN KETTERING CANCER CENTER
优先权: 2007
EP
US
7 件公开
Glycolipids and analogues thereof as antigens for NKT cells
US 7923013 B2
申请人: UNIV ROCKEFELLER
优先权: 2007
US
7 件公开
CHIMERIC ANTIGEN RECEPTOR AND NATURAL KILLER CELLS EXPRESSING SAME
EP 3567049 A4
申请人: GREEN CROSS LAB CELL CORP
优先权: 2016
CN
EP
US
WO
6 件公开
NUCLEIC ACID SEQUENCE ENCODING A CS1-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) POLYPEPTIDE
EP 3663320 A1
申请人: OHIO STATE INNOVATION FOUNDATION
优先权: 2013
CN
EP
US
6 件公开
THERAPEUTIC PREPARATIONS OF GAMMA-DELTA T CELLS AND NATURAL KILLER CELLS AND METHODS FOR MANUFACTURE AND USE
EP 3827074 A2
申请人: OSPEDALE PEDIATRICO BAMBINO GESÙ
优先权: 2018
CN
EP
US
WO
5 件公开
TREATMENT OF AUTOIMMUNE DISEASES WITH ENGINEERED IMMUNE CELLS
EP 4511057 A1
申请人: CARIBOU BIOSCIENCES INC
优先权: 2022
CN
EP
US
WO
5 件公开
COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
EP 4098275 A1
申请人: MEMORIAL SLOAN KETTERING CANCER CENTER
优先权: 2013
CN
EP
US
5 件公开
EP 3811954 A1
申请人: MEMORIAL SLOAN KETTERING CANCER CENTER
优先权: 2013
EP
TARGETING MOIETY-DRUG GRAFTED IMMUNE CELL COMPOSITIONS AND METHODS OF USE
EP 3853258 A4
申请人: UNIV ARIZONA
优先权: 2018
EP
US
WO
5 件公开
第 1 / 10 页
上一页
下一页
药物
反馈